Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors
Provided By GlobeNewswire
Last update: May 22, 2025
Dr. Read brings >30 years of leadership and scientific expertise in the biopharmaceutical industry
Previously served as CEO and Founder of Mariana Oncology until its acquisition by Novartis in 2024 and CSO of Ra Pharma until its acquisition by UCB in 2020
Read more at globenewswire.com
